November 25, 2004
Estrogen Use and Ovarian Cancer Risk
"The estrogen component of oral hormone replacement therapy around the time of menopause is associated with ovarian cancer risk, findings from a Danish study show."
Related Stories
"The estrogen component of oral hormone replacement therapy around the time of menopause is associated with ovarian cancer risk, findings from a Danish study show."
